Events Search and Views Navigation
May 2020
ASGCT 23rd Annual Meeting
The ASGCT 23rd Annual Meeting will be the world’s largest gathering of gene and cell therapy researchers and provides an international forum where the latest scientific developments are presented and critically discussed.
Viroclinics team members will showcase clinical diagnostic services to detect AAVs in clinical samples.
September 2020
World Vaccine Congress Washington 2020
The 20th Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer and emerging diseases. The conference tackles the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. We will present our views on how R&D outsourcing can stimulate the innovation processes for vaccine developers. Practical case examples will be…
Find out more »October 2020
Webinar: Towards a polio free world, the importance and GAP III requisites of (pre)clinical analyses models
This webinar looks at the challenges surrounding (pre)clinical diagnostics and highlights the main GAP III regulatory directives and policies applicable to a polio essential facility. We invite you to join us for a webinar (hosted by the Developing Countries Vaccine Manufacturers Network and Viroclinics-DDL) to learn from our experts about their experiences, operational insights and best practices. Our goal is to ultimately contribute to a polio free world.
Find out more »April 2021
Translating SARS-CoV-2 clinical trial challenges into lasting solutions – Key learnings from the perspective of an end-to-end virology Contract Research Organization
This webinar took place on April 30. A recorded version is available here. Bringing together expertise across a broad domain of preclinical, clinical trial diagnostics, supply chain and bioinformatics services to support the continuous battle against SARS-CoV-2 As SARS-CoV-2 continues to spread across the globe, pharma and biotech companies remain committed to find effective vaccines and therapeutics. Communities are still affected and we are far from a manageable situation. With newly emerging variants in the UK, South-Africa and Brazil…
Find out more »May 2021
World Vaccine Congress Washington 2021
The 21st Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer and emerging diseases. The conference tackles the latest issues affecting vaccines for respiratory diseases including SARS-CoV-2 to stimulate the industry to develop more effective vaccines. We will present our views on how R&D outsourcing can stimulate the innovation processes for vaccine developers. Practical case examples will be discussed and new horizons will be explored by sharing our latest research insights.
Find out more »
